CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflect

Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript

Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price t

Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price targ

CryoPort NASDAQ: CYRX reported second-quarter 2026 revenue of $49 million and said it reached positi

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.2 per share in line with the Zacks Consen

CryoPort (NASDAQ:CYRX) affirms FY2026 sales outlook from $192.000 million-$196.000 million to $192.0

CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.20) per share which missed the analyst conse

Second quarter revenue grew 8% year-over-year to $49.0 million Life Sciences Services revenue increa

BTIG analyst David Larsen maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target

NASHVILLE, Tenn., July 23, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Co

IntegriCell Provides Process Development, Technology Transfer, and Clinical Cryopreservation Service

IntegriCell Provides Process Development, Technology Transfer, and Clinical Cryopreservation Service

Craig-Hallum analyst Matthew Hewitt maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the pr

Keybanc analyst Paul Knight maintains CryoPort (NASDAQ:CYRX) with a Overweight and raises the pri

Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price t

Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price targ

BTIG analyst David Larsen maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target

Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus E

Cryoport released financial results for Q1 of fiscal 2026 Monday after the closing bell.

CryoPort (NASDAQ:CYRX) raises FY2026 sales outlook from $190.000 million-$194.000 million to $192.00

CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.25) per share which missed the analyst conse

First quarter revenue grew 16% year-over-year to $47.8 million Commercial cell and gene therapy (CGT

NASHVILLE, Tenn., April 20, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "C

Cryoport receives a buy rating with a $9.1 price target, implying 17% upside by FY 2026. CYRX demons

Craig-Hallum analyst Matthew Hewitt initiates coverage on CryoPort (NASDAQ:CYRX) with a Buy ratin

CryoPort, Inc. (NASDAQ: CYRX - Get Free Report) has received a consensus recommendation of "Moderate

Wall Street analysts changed outlook on top names. For full view of changes, including upgrades/down

Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price targ

Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus E

CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.17) per share which beat the analyst consens

FY 2025 revenue increased to $176.2 million, exceeding the high end of previous guidance Life Scienc

NASHVILLE, Tenn., Feb. 17, 2026 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Co

Self-Sustaining Fusion® 800 Series  Cryogenic Freezer Delivers High-Capacity Storage, Flexibility, a

Cryoport, Inc. launched the Fusion 800 Series, a compact cryogenic storage system that eliminates th

Cryoport, Inc. launched the Fusion® 800 Series, a compact cryogenic storage system that eliminates t

CEO Mike Duich says '"Fusion 800 delivers the storage density, flexibility, and operational

CryoPort (NASDAQ: CYRX - Get Free Report) and Royal Mail (OTCMKTS:ROYMY - Get Free Report) are both